Bayer supports demining in Ukraine with donation to non-profit "Fondation suisse de déminage"
- Details
- Category: Bayer

Pfizer announces positive top-line results from Phase 3 study of 20-valent pneumococcal conjugate vaccine in infants
- Details
- Category: Pfizer

Roche announces U.S. FDA approval of Xofluza to treat influenza in children aged five years and older
- Details
- Category: Roche

Pfizer to acquire Global Blood Therapeutics for $5.4 billion to enhance presence in rare hematology
- Details
- Category: Pfizer

Roche's subcutaneous formulation of Tecentriq demonstrates positive Phase III results
- Details
- Category: Roche

Bayer Consumer Health leaders propose new principles for science-led self-care
- Details
- Category: Bayer

GSK signs agreement to support pandemic preparedness in Europe
- Details
- Category: GlaxoSmithKline

More Pharma News ...
- Pfizer and BioNTech advance COVID-19 vaccine strategy with study start of next-generation vaccine candidate based on enhanced spike protein design
- AstraZeneca to acquire TeneoTwo and its clinical-stage T-cell engager
- Pfizer and BioNTech complete submission to European Medicines Agency for Omicron BA.1 adapted bivalent vaccine candidate
- Bayer to sell men's health product Nebido™ to Grünenthal
- Lilly will supply an additional 150,000 doses of bebtelovimab to U.S. government
- Sanofi Global Health launches nonprofit Impact® brand for 30 medicines in low-income countries
- Boehringer Ingelheim, Evotec and bioMérieux launch Aurobac, a joint venture to fight Antimicrobial Resistance